Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Living Image Software Enhances Fluorescent Sensitivity and Automated 3D image Acquisition and Analysis

By LabMedica International staff writers
Posted on 14 Jan 2010
New software has been designed with advanced tools for quantitative three-dimensional (3D) molecular imaging, bioluminescence, and fluorescence spectral unmixing of small animals.

Caliper Life Sciences, Inc. More...
(Hopkinton, MA, USA), a provider of tools and services for drug discovery and life sciences research, recently introduced Living Image 4.0 software for IVIS in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide. Living Image 4.0 features advanced spectral unmixing tools to enhance fluorescent sensitivity and automated 3D image acquisition and analysis providing an anatomic view of disease activity and drug efficacy.

Preclinical imaging for translational research is now routinely used in large-scale studies for drug discovery and vaccine development. With Living Image 4.0, scientists can easily visualize and track diseases quantitatively, in small living animals through the sensitive detection of fluorescent and bioluminescent reporters and functional markers. 3D images generated with Living Image 4.0 can also be coregistered with computed tomography (CT) or magnetic resonance imaging (MRI) results to provide enhanced anatomic context for optical molecular signals.

The software's new design creates an intuitive workflow for researchers of all skill levels. New features include: wizard based guidance for advanced imaging protocols, improved surface tomography, advanced spectral unmixing tools, new color templates, and 3D visualization tools. All IVIS systems are calibrated to U.S. National Institute of Standards and Technology (NIST) standards to ensure that quantitative results are validated throughout an experiment and from location to location.

"Caliper's IVIS systems are widely recognized as the leading small animal molecular imaging instrument for drug discovery and development,” said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "Living Image 4.0 will further enhance IVIS' value to scientists by improving its ease-of-use, quantization, and reproducibility.”

Related Links:

Caliper Life Sciences



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Hemodynamic System Monitor
OptoMonitor
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.